Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: Correlation between genotype and clinical features

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 6, 1996, Pages 565-572

  Radunovic A ^a,b   Leigh, P N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030450004     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.6.565     Document Type: Review

References (82)

1. Charcot JM, Jeffrey A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moelle épinière. Arch Physiol Neurol Path 1869;2:744-60.
2. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
3. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurology 1986;366:511-7.
4. Veltema AN, Roos RAC, Bruyn GW. Autosomal dominant adult amyotrophic lateral sclerosis. J Neurol Sci 1990;97: 93-115.
5. Li T-M, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neurone disease. J Neurol Neurosurg Psychiatry 1988;51:778-84.
6. Emery AEH, Holloway S. Familial motor neuron diseases. In: Rowland LP, ed. Human motor neuron diseases. Advances in neurology. Vol 36, New York: Raven Press, 1983:139-47.
7. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344: 721-4.
8. Hodgson EK, Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 1975;14:5294-9.
9. Yim MB, Chock PB, Stadtman ER. Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J Biol Chem 1993;268:4099-105.
10. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993;364:584.
11. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Grall EB, Roe JA, Lee MK, Valentine JS, Bredesen DE. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-8.
12. Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, Bernstein Y, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J 1985;4:77-84.
13. Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993; 261:1047-51.
14. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K. Mild ALS in Japan associated with novel SOD mutation. Nature Genet 1993:5:323-4; Erratum Nature Genet 1994;6:225.
15. Kurahashi K, Okushima T, Kimura K, Narita S, Matsunaga M. Different phenotype and clinical course in a family with motor neuron disease. Medical Journal of Aomori 1993;38:142-6.
16. Nakano R, Sato S, Inuzuka T, Sakimura K, Mishina M, Takahashi H, et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994;200: 695-703.
17. 7 → Glu deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994;204:572-7.
18. Elshafey A, Lanyon WG, Connor JM. Identifaction of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase SOD-1 gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:363-4.
19. Esteban J, Rosen DR, Bowling AC, Sapp P, McKenna-Yasek D, O'Regan JP, et al. Identifaction of two mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:997-8.
20. Kostrzewa M, Burck-Lehmann U, Müller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene. Hum Mol Genet 1994;3:2261-2.
21. Aoki M, Abe K, Houi K, Ogasawara M, Matsubara Y, Kobayashi T, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 1995;37:676-9.
22. Pramatorova A, Figlewicz DA, Krizus A, Han FY, Ceballos-Picot I, Nicole A, et al. Identification of new mutations in the Cu/Zn superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995;56:592-6.
23. Andersen PM, Nilsson P, Ala-Hurula V, Keränen M-L, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics 1995; 10:61-6.
24. Ikeda M, Abe K, Aoki M, Ogasawara M, Kameya T, Watanabe M, et al. A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995;4:491-2.
25. Sapp PC, Rosen DR, Hosler BA, Esteban J, McKenna-Yasek D, O'Regan JP, et al. Identifaction of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromusc Disord 1995;5:353-7.
26. Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EMC. An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet 1995;4:1101-4.
27. Deng H-X, Tainer JA, Mitsumoto H, Ohnishi A, He X, Hung W-Y, et al. Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995;4:1113-6.
28. Enayat ZE, Orrell RW, Claus A, Ludolph A, Bachus R, Brockmüller J, et al. Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995;4: 1239-40.
29. Moulard B, Camu W, Brice A, Salachas F, Meininger V, Malafosse A. A previously undescribed mutation in the SOD1 gene in a French family with atypical ALS. 6th International Symposium on ALS/MND, Pathogenesis and treatment of ALS/MND II, Dublin, 1995 [abstract].
30. de Belleroche J, Orrell R, Marklund S, Hallewell R, Bowe F. Functional and structural correlates of 12 superoxide dismutase-1 mutations in UK families with amyotrophic lateral sclerosis. 6th International Symposium on ALS/ MND, Fathogenesis and treatment of ALS/MND II, Dublin, 1995 [abstract].
31. Abe K, Aoki M, Ikeda M, Watanabe M, Hirai S, Itoyama Y. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci 1996;136:108-16.
32. Watanabe M, Aoki M, Abe K, Shoji M, Iizuka T, Ikeda Y, et al. A novel missense point mutation S134N of the Cu/Zn superoxide dismutase gene in a patient with familal motor neuron disease. Hum Mutat 1996 (in press).
33. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994;3: 649-50.
34. Jones CT, Shaw PJ, Chari G, Brock DJH. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994;8:329-30.
35. Jones CT, Brock DJH, Chancellor AM, Warlow CP, Swingler RJ. Cu/Zn superoxide dismutase SOD1 mutations and sporadic amyotrophic lateral sclerosis. Lancet 1993;342:1050-1.
36. Kawamata J, Shimohama S, Hasegawa H, Imura T, Kimura J, Ueda K. Deletion and point mutations in superoxide dismutase-1 gene in amyotrophic lateral sclerosis. XIth TMIN International Symposium: amyotrophic lateral sclerosis, progress and perspectives in basic research and clinical application, Tokyo, 1995 [abstract].
37. Morita M, Aoki M, Abe K, Hasegawa T, Sakuma R, Onodera Y, et al. A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial ALS in Japan. Neurosci Lett 1996;205:79-82.
38. Pramatorova A, Goto J, Nanba E, Nakashima K, Takahashi K, Takagi A, et al. A two basepair deletion in the SOD 1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:2061-2.
39. Bannister WH, Bannister JV, Barra D, Bond J, Bossa F. Evolutionary aspects of superoxide dismutase: the copper/zinc enzyme. Free Rad Res Commun 1991;12-13: 349-61.
40. Rosen DR, Bowling AC, Patterson D, Usdin T, Sapp P, Mezey E, et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:981-7.
41. Bowling AC, Barkowski EE, McKenna-Yasek D, Sapp P, Horvitz HR, Beal MF, Brown RH Jr. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995;64:2366-69.
42. Rainero I, Pinessi L, Tsuda T, Vignocchi MG, Vaula G, Calvi L, et al. SOD1 missense mutation in an Italian family with ALS. Neurology 1994;44:347-9.
43. 106 → Val CTC → GTC mutation of superoxide dismutase-1 gene in patient with familial amyotrophic lateral sclerosis in Japan. Lancet 1994;343:1501.
44. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994;344:1773.
45. Jones CT, Swingler RJ, Simson SA, Brock DJH. Superoxide dismutase in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32:290-92.
46. Robberecht W, Sapp P, Viaene MK, Rosen D, McKenna-Yasek D, Haines J, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994;62:384-7.
47. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K. Familial amyotrophic lateral sclerosis ALS in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci 1994;126: 77-83.
48. Orrell R, de Belerroche J, Marklund S, Bowe F, Hallewell R. A novel SOD mutant and ALS. Nature 1995;374:504-5.
49. 100 → gly in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995;189:143-46.
50. Nakashima K, Watanabe Y, Kuno N, Nanba E, Takahashi K. Abnormality of Cu/Zn superoxide dismutase SOD1 activity in Japanese familial amyotrophic lateral sclerosis with two base pair deletion in the SOD1 gene. Neurology 1995;45:1019-20.
51. Aksoy H, Siddique T, Dean G. Familial amyotrophic lateral sclerosis in the Turkish community of Cyprus. 6th International Symposium on ALS/MND, Pathogenesis and treatment of ALS/MND II, Dublin, 1995 [abstract].
52. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogenity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995;59: 266-70.
53. Cleveland D, Laing N, Hurse PV, Brown RH Jr. Toxic mutant in Charcot's sclerosis. Nature 1995;378:342-3.
54. Rouleau GA, Clark AW, Rooke K, Pramatorova A, Krizus A, Suchowersky O, Julien J-P, Figlewicz D. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996;39: 128-131.
55. Robberecht W, Aguirre T, Van Den Bosch L, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996 (in press).
56. Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keränen M-L, et al. A clinical and genealogical study of 36 patients. Brain 1996;119:1153-72.
57. Figlewicz DA, Garruto RM, Krizus A, Yanagihara R, Rouleau GA. The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam. NeuroReport 1994;5:557-60.
58. Parboosingh JS, Roussaeau M, Rogan F, Amit Z, Chertkow H, Johnson WG, et al. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease. Arch Neurol 1995;52,1160-3.
59. Sculley DG, Dawson PA, Emmerson BT, Gordon RB. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase HPRT deficiency. Hum Genet 1992;90:195-207.
60. Takahashi T, Suchi M, Desnick RJ, Takada G, Schuchman EH. Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. J Biol Chem 1992;267:12552-8.
61. Norris F, Shepherd R, Denys E, Kwei V, Mukai E, Elias L. Onset, natural history and outcome in idiopathic motor neuron disease. J Neurol Sci 1993;118:48-55.
62. Leigh PN, Ray Chaudhuri K. Motor neuron disease. J Neurol Neurosurg Psychiatry 1994;57:886-96.
63. Kurland LT, Mulder DW. Epidemiological investigations of amyotrophic lateral sclerosis. II Familial aggregations indicative of dominant inheritance. Neurology 1955;5: 182-96; 249-68.
64. Swerts L, van den Bergh R. Sclerose laterale amyotrophique familiale. Journal de Genetique Humaine 1976; 24:247-55.
65. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence, and distribution since 1950. J Neurol Neurosurg Psychiatry 1992;55: 1106-15.
66. Takahashi H, Makifuchi T, Nakano R, Sato S, Inuzuka T, Sakimura K, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol (Berl) 1994;88:185-8.
67. Shaw CE, Anderson VER, Al-Sarraj S, Lantos PL, Leigh PN. Molecular pathology of familial amyotrophic lateral sclerosis ALS with a mutation of SOD1 [abstract]. Neuropathol Appl Neurobiol 1996;22:154.
68. Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene - pathological and immunocytochemical changes. Acta Neuropathol 1996; 92:395-403.
69. Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson PH. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene - pathological and immunocytochemical changes. Acta Neuropathol 1996;92:395-403.
70. Leigh PN, Swash M. Cytoskeletal pathology in motor neuron diseases. In: Rowland LP, eds. Amyotrophic lateral sclerosis and other motor neuron diseases. Advances in Neurology. Vol 56. New York: Raven Press, 1991: 115-24.
71. Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, Julien J-P. Variants of heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994;3: 1757-61.
72. Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994;13:975-88.
73. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu Z-S, Wong P-C, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91: 8292-6.
74. Tsuda T, Munthasser S, Fraser PE, Percy ME, Rainero I, Vaula G, et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994;13:727-36.
75. Bowling AC, Shulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993;61:2322-5.
76. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-16.
77. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-5.
78. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995; 92:689-93.
79. Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995;378:776-9.
80. Avraham KB, Schickler M, Sapoznikov D, Yarom R, Groner Y. Down's syndrome: abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase. Cell 1988;54: 823-9.
81. Brown RH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995;80:687-92.
82. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39:147-57.